Ardent Health, Inc.
NYSEARDT reports Q2 2026 results on August 5 against a backdrop where close peers have rallied sharply while the stock itself has lagged — a gap the print will need to close or explain. The peer divergence is the sharpest tension heading into the release. HCA gained 4.4% on the week, UHS added 6.1%, and RDNT surged 8.6%. ARDT, by contrast, fell…
ARDT cost to borrow surges 139% in one week to 0.48%, though availability remains abundant at 244% of short interest.
Snapshot as of 19 Aug 2026
ARDT reports Q2 2026 results on August 5 against a backdrop where close peers have rallied sharply while the stock itself has lagged — a gap the print will need to close or explain. The peer divergence is the sharpest…
Ardent Health enters June trading against a sector-wide downdraft — hospital peers fell hard last week — but the stock itself stayed relatively anchored, down just 0.2% on the week while close comparables like UHS and…
Ardent Health enters the back half of its earnings week with fresh momentum — a Q1 beat and held guidance have pushed the stock to its best level in months, yet the Street's cumulative target cuts tell a more…
Ardent Health heads into its May 6 earnings call with the headline numbers already on the table — a Q1 beat that punched through modest expectations. The company posted Q1 EPS of $0.28, well clear of the $0.20…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ARDT — free to start on ORTEX.
Sign up for free →Open ARDT on ORTEX